Olav Dalgård
University of Oslo · 204 works · 14,094 citations · h-index 46
Top works
- EASL Recommendations on Treatment of Hepatitis C 2018
- Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
- EASL recommendations on treatment of hepatitis C: Final update of the series☆
- Treatment With Pegylated Interferon and Ribavarin in Hcv Infection With Genotype 2 Or 3 for 14 Weeks: A Pilot Study
- A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
- Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
- Elbasvir–Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy
- Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
- Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C
- Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial
- Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response
- The present and future disease burden of hepatitis C virus ( HCV ) infections with today's treatment paradigm – volume 2
- Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
- Treatment of Chronic Hepatitis C in Injecting Drug Users: 5 Years’ Follow-Up
- Recommendations for the management of hepatitis C virus infection among people who inject drugs
- Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trials
- Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe
- Follow‐Up Studies of Treatment for Hepatitis C Virus Infection among Injection Drug Users
- Historical epidemiology of hepatitis C virus ( HCV ) in select countries – volume 2
- CMV drives clonal expansion of NKG2C + NK cells expressing self‐specific KIRs in chronic hepatitis patients